Co-Diagnostics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CODX research report →
Companyco-dx.com
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
- CEO
- Dwight H. Egan
- IPO
- 2017
- Employees
- 132
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $2.67M
- P/E
- -0.11
- P/S
- 3.71
- P/B
- 0.34
- EV/EBITDA
- 0.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 9.49%
- Op Margin
- -4447.41%
- Net Margin
- -6753.69%
- ROE
- -164.92%
- ROIC
- -170.99%
Growth & Income
- Revenue
- $622.49K · -84.10%
- Net Income
- $-46,895,936 · -24.59%
- EPS
- $-35.25 · 5.24%
- Op Income
- $-31,283,352
- FCF YoY
- 0.22%
Performance & Tape
- 52W High
- $46.50
- 52W Low
- $1.26
- 50D MA
- $1.88
- 200D MA
- $6.68
- Beta
- 1.26
- Avg Volume
- 3.39M
Get TickerSpark's AI analysis on CODX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 23, 25 | Murphy Edward L. | other | 57,499 |
| Nov 23, 25 | Murphy Edward L. | other | 57,499 |
| Nov 23, 25 | Brown Brian Lee | other | 134,167 |
| Nov 23, 25 | Brown Brian Lee | sell | 40,723 |
| Nov 23, 25 | Brown Brian Lee | other | 134,167 |
| Nov 23, 25 | Abbott Richard David | other | 56,667 |
| Nov 23, 25 | Abbott Richard David | other | 56,667 |
| Nov 23, 25 | Abbott Richard David | sell | 17,200 |
| Nov 23, 25 | Egan Dwight H | other | 163,333 |
| Nov 23, 25 | Egan Dwight H | sell | 49,575 |
Our CODX Coverage
We haven't published any research on CODX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CODX Report →